Brief: Ginkgo Bioworks Receives Grant To Develop Live Cell Delivery Platform Of Antibody Therapeutics For Treating HIV And Malaria
Dec 13 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N :
* GINKGO BIOWORKS RECEIVES GRANT TO DEVELOP INNOVATIVE LIVE
CELL
DELIVERY PLATFORM OF ANTIBODY THERAPEUTICS FOR TREATING HIV AND
MALARIA
* GINKGO - WILL FOCUS ON CREATING PROTOTYPE ENGINEERED CELL
LINE
THAT CAN EXPRESS ANTIBODIES FOR TREATMENT OF HIV AND/OR MALARIA
VIA IMPLANTABLE DEVICE
Source text for Eikon: ID:nPnbJVnQya
Further company coverage: DNA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ginkgo Bioworks Holdings
See all newsUS STOCKS ON THE MOVE-NiSource, Hewlett Packard, Sandisk
US STOCKS ON THE MOVE-CoreWeave, Moderna, Fox Corp
Brief: Ginkgo Bioworks To Provide Autonomous Lab Access To Nsf X-Labs Researchers
US weighs allowing most pharma licensing deals with China, sources say
Ginkgo Bioworks Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary